Acute superior mesenteric artery occlusion associated with COVID-19 pneumonia: a case report. 2022

Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
Department of Surgery, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

BACKGROUND The novel 2019 coronavirus disease (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2, has spread rapidly around the world and has caused many deaths. COVID-19 involves a systemic hypercoagulable state and arterial/venous thrombosis which induces unfavorable prognosis. Herein, we present a first case in East Asia where an acute superior mesenteric artery (SMA) occlusion associated with COVID-19 pneumonia was successfully treated by surgical intervention. METHODS A 70-year-old man presented to his local physician with a 3-day history of cough and diarrhea. A real-time reverse transcriptase-polymerase chain reaction test showed positive for COVID-19, and he was admitted to the source hospital with the diagnosis of moderate COVID-19 pneumonia. Eight days later, acute onset of severe abdominal pain appeared with worsening respiratory condition. Contrast CT showed that bilateral lower lobe/middle lobe and lingula ground glass opacification with distribution suggestive of COVID-19 pneumonia and right renal infarction. In addition, it demonstrated SMA occlusion with intestinal ischemia suggesting extensive necrosis from the jejunum to the transverse colon. The patient underwent an emergency exploratory laparotomy with implementing institutional COVID-19 precaution guideline. Upon exploration, the intestine from jejunum at 100 cm from Treitz ligament to middle of transverse colon appeared necrotic. Necrotic bowel resection was performed with constructing jejunostomy and transverse colon mucous fistula. We performed second surgery to close the jejunostomy and transverse colon mucous fistula with end-to-end anastomosis on postoperative day 22. The postoperative course was uneventful and he moved to another hospital for rehabilitation to improve activities of daily living (ADLs) on postoperative day 45. As of 6 months after the surgery, his ADLs have completely improved and he has returned to social life without any intravenous nutritional supports. CONCLUSIONS Intensive treatment including surgical procedures allowed the patient with SMA occlusion in COVID-19 pneumonia to return to social life with completely independent ADLs. Although treatment for COVID-19 involves many challenges, including securing medical resources and controlling the spread of infection, when severe abdominal pain occurs in patients with COVID-19, physicians should consider SMA occlusion and treat promptly for life-saving from this deadly combination.

UI MeSH Term Description Entries

Related Publications

Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
April 1969, Annals of surgery,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
April 1972, Angiology,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
November 2021, Cureus,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
February 1971, The American journal of gastroenterology,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
August 2022, Cureus,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
December 2020, The Indian journal of surgery,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
January 2024, Cureus,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
January 2024, AME case reports,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
November 2008, Gastrointestinal endoscopy,
Masahiro Sukegawa, and Satoshi Nishiwada, and Taichi Terai, and Hiroyuki Kuge, and Fumikazu Koyama, and Kenji Nakagawa, and Minako Nagai, and Masayuki Sho
January 2009, Khirurgiia,
Copied contents to your clipboard!